Idorsia Ltd (SWX:IDIA)
Switzerland · Delayed Price · Currency is CHF
3.555
-0.055 (-1.52%)
Apr 2, 2026, 2:30 PM CET
Revenue by Segment
Financials in millions CHF. Fiscal year is January - December.
Millions CHF. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 |
|---|
Innovative Medicines for Unmet Medical Needs | 220.58M | 112.51M | 152.39M | 97.10M | 35.35M | | | | | |
Innovative Medicines for Unmet Medical Needs Growth | 96.06% | -26.17% | 56.93% | 174.70% | -50.74% | | | | | |
| 220.58M | 112.51M | 152.39M | 97.10M | 35.35M | | | | | |
| 96.06% | -26.17% | 56.93% | 174.70% | -50.74% | | | | | |
Revenue by Geography
Financials in millions CHF. Fiscal year is January - December.
Millions CHF. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 |
|---|
| 90.74M | 51.11M | 88.03M | 46.58M | 35.35M | | | | | |
| 77.53% | -41.94% | 88.99% | 31.77% | -50.74% | | | | | |
| 26.99M | 28.60M | 24.41M | 5.54M | - | | | | | |
| -5.62% | 17.17% | 340.36% | - | - | | | | | |
| 67.43M | 11.98M | - | - | - | | | | | |
| 462.78% | - | - | - | - | | | | | |
| 35.42M | 20.81M | 6.28M | 1.00M | - | | | | | |
| 70.16% | 231.21% | 525.90% | - | - | | | | | |
| - | - | 33.66M | 43.98M | - | | | | | |
| - | - | -23.45% | - | - | | | | | |
| 220.58M | 112.51M | 152.39M | 97.10M | 35.35M | | | | | |
| 96.06% | -26.17% | 56.93% | 174.70% | -50.74% | | | | | |
Source: S&P Global Market Intelligence.